Redactie
Hy2Care BV, a spin-off of the University of Twente founded by professor Marcel Karperien, has managed to raise € 3.7 million in funding. The startup, which has developed injectable hydrogels for the treatment of cartilage defects, will now be able to commercialize its technology for veterinary use as well as initiate human trials.
